Whitehawk Therapeutics Stock (NASDAQ:WHWK)
Previous Close
$3.83
52W Range
$1.57 - $5.50
50D Avg
$4.23
200D Avg
$3.27
Market Cap
$183.47M
Avg Vol (3M)
$478.06K
Beta
0.77
Div Yield
-
WHWK Company Profile
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.